tuvirumab
sevirumab
imciromab
maslimomab
nebacumab
biciromab
enlimomab
satumomab
altumomab
edobacomab
detumomab
daclizumab
votumumab
abciximab
capromab
regavirumab
inolimomab
priliximab
afelimomab
odulimomab
arcitumomab
igovomab
edrecolomab
faralimomab
technetium (99mTc) pintumomab
bectumomab
sulesomab
nerelimomab
keliximab
cedelizumab
basiliximab
lintuzumab
infliximab
rituximab
clenoliximab
felvizumab
trastuzumab
morolimumab
atorolimumab
natalizumab
palivizumab
vepalimomab
minretumomab
tositumomab
epitumomab
adalimumab
sibrotuzumab
rovelizumab
mepolizumab
lerdelimumab
cetuximab
epratuzumab
mitumomab
bivatuzumab
alemtuzumab
ruplizumab
bevacizumab
gemtuzumab
omalizumab
lemalesomab
visilizumab
gavilimomab
ziralimumab
erlizumab
metelimumab
matuzumab
reslizumab
efalizumab
labetuzumab
pritumumab
technetium (99mTc) fanolesomab
pexelizumab
oregovomab
vapaliximab
apolizumab
teneliximab
pascolizumab
eculizumab
toralizumab
ecromeximab
siplizumab
fontolizumab
urtoxazumab
aselizumab
zanolimumab
ranibizumab
bertilimumab
galiximab
talizumab
elsilimomab
pertuzumab
belimumab
tocilizumab
catumaxomab
ertumaxomab
sontuzumab
lumiliximab
adecatumumab
besilesomab
libivirumab
golimumab
panitumumab
tefibazumab
exbivirumab
nimotuzumab
ipilimumab
raxibacumab
volociximab
zalutumumab
ofatumumab
bapineuzumab
mapatumumab
ocrelizumab
pagibaximab
tadocizumab
denosumab
efungumab
abagovomab
stamulumab
motavizumab
iratumumab
tremelimumab
bavituximab
lexatumumab
ibalizumab
tenatumomab
canakinumab
etaracizumab
otelixizumab
teplizumab
lucatumumab
panobacumab
gantenerumab
milatuzumab
veltuzumab
tanezumab
anrukinzumab
ustekinumab
dacetuzumab
tigatuzumab
racotumomab
blinatumomab
conatumumab
obinutuzumab
siltuximab
rafivirumab
foravirumab
farletuzumab
elotuzumab
necitumumab
figitumumab
robatumumab
vedolizumab
solanezumab
ramucirumab
cixutumumab
teprotumumab
rontalizumab
girentuximab
iodine (124I) girentuximab
rilotumumab
daratumumab
intetumumab
sifalimumab
fezakinumab
briakinumab
fresolimumab
lebrikizumab
secukinumab
suvizumab
glembatumumab
dalotuzumab
benralizumab
mavrilimumab
tralokinumab
drozitumab
enokizumab
etrolizumab
ensituximab
samalizumab
olaratumab
foralumab
gevokizumab
oxelumab
itolizumab
ponezumab
ganitumab
olokizumab
ublituximab
roledumab
atinumab
radretumab
amatuximab
enavatuzumab
urelumab
onartuzumab
ozoralizumab
icrucumab
carlumab
fulranumab
mogamulizumab
vesencumab
namilumab
tregalizumab
lirilumab
pateclizumab
tabalumab
sirukumab
vatelizumab
blosozumab
narnatumab
ficlatuzumab
ixekizumab
brodalumab
sarilumab
crenezumab
abituzumab
caplacizumab
inclacumab
ontuxizumab
flanvotumab
romosozumab
solitomab
quilizumab
patritumab
placulumab
actoxumab
demcizumab
enoticumab
lampalizumab
fasinumab
ocaratuzumab
imgatuzumab
clazakizumab
bezlotoxumab
vorsetuzumab
futuximab
modotuximab
alirocumab
nivolumab
simtuzumab
orticumab
concizumab
evolocumab
duligotuzumab
parsatuzumab
perakizumab
ligelizumab
dupilumab
tildrakizumab
dusigitumab
nesvacumab
pidilizumab
idarucizumab
ozanezumab
seribantumab
bimagrumab
pritoxaximab
setoxaximab
lodelcizumab
eldelumab
dinutuximab
tosatoxumab
codrituzumab
tarextumab
guselkumab
tovetumab
vantictumab
pembrolizumab
margetuximab
anifrolumab
atezolizumab
obiltoxaximab
otlertuzumab
aducanumab
bococizumab
ralpancizumab
ulocuplumab
fletikumab
bimekizumab
abrilumab
diridavumab
emibetuzumab
varlilumab
pasotuxizumab
vanucizumab
emactuzumab
lumretuzumab
begelomab
imalumab
lenzilumab
firivumab
navivumab
brontictuzumab
inebilizumab
lokivetmab
durvalumab
evinacumab
andecaliximab
lendalizumab
elgemtumab
tesidolumab
brolucizumab
dectrekumab
pamrevlumab
avelumab
nemolizumab
sapelizumab
isatuximab
lilotomab
indusatumab
trevogrumab
opicinumab
ascrinvacumab
monalizumab
bleselumab
emicizumab
cabiralizumab
plozalizumab
risankizumab
xentuzumab
rovalpituzumab
ifabotuzumab
enoblituzumab
tezepelumab
refanezumab
rinucumab
afasevikumab
tisotumab
mirvetuximab
landogrozumab
blontuvetmab
tamtuvetmab
crotedumab
rivabazumab
vobarilizumab
rozanolixizumab
navicixizumab
prezalumab
laprituximab
naratuximab
vadastuximab
carotuximab
timolumab
lupartumab
depatuxizumab
lanadelumab
pogalizumab
galcanezumab
domagrozumab
erenumab
fremanezumab
burosumab
suptavumab
eptinezumab
crizanlizumab
emapalumab
elezanumab
remtolumab
lutikizumab
dezamizumab
telisotuzumab
aprutumab
utomilumab
vunakizumab
camrelizumab
rosmantuzumab
sacituzumab
tavolixizumab
ranevetmab
brazikumab
